Astrazeneca Pharma India Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 9.39% vs 6.23% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -39.89% vs -2.88% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -40.37% vs -7.31% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 58.21% vs -6.94% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Astrazeneca Phar With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

611.57

645.03

-33.46

-5.19%

Other Operating Income

0.00

Total Operating income

611.57

645.03

-33.46

-5.19%

Raw Material Cost

0.00

67.78

-67.78

-100.00%

Purchase of Finished goods

697.12

145.15

551.97

380.28%

(Increase) / Decrease In Stocks

-330.73

11.84

-342.57

-2,893.33%

Employee Cost

93.78

100.30

-6.52

-6.50%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

35.84

0.00

35.84

Other Expenses

70.73

91.77

-21.04

-22.93%

Total Expenditure (Excl Depreciation)

566.74

416.84

149.90

35.96%

Operating Profit (PBDIT) excl Other Income

44.83

228.19

-183.36

-80.35%

Other Income

5.13

38.21

-33.08

-86.57%

Operating Profit (PBDIT)

49.96

266.40

-216.44

-81.25%

Interest

1.06

1.99

-0.93

-46.73%

Exceptional Items

1.48

-58.20

59.68

102.54%

Gross Profit (PBDT)

50.38

206.21

-155.83

-75.57%

Depreciation

3.84

14.26

-10.42

-73.07%

Profit Before Tax

46.54

191.95

-145.41

-75.75%

Tax

13.95

50.11

-36.16

-72.16%

Provisions and contingencies

0.00

Profit After Tax

32.59

141.84

-109.25

-77.02%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

32.59

141.84

-109.25

-77.02%

Equity Capital

5.00

45.75

-40.75

-89.07%

Face Value

2.00

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

13.04

31.00

-17.96

-57.94%

Diluted Earnings per share

13.04

31.01

-17.97

-57.95%

Operating Profit Margin (Excl OI)

7.33%

35.38%

0.00

-28.05%

Gross Profit Margin

8.24%

31.97%

0.00

-23.73%

PAT Margin

5.33%

21.99%

0.00

-16.66%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 611.57 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 9.39% vs 6.23% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 38.90% vs 43.98% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 32.59 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -39.89% vs -2.88% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 5.64% vs 95.25% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 44.83 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -40.37% vs -7.31% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -41.77% vs 411.56% in Dec 2024

Quarterly - Interest

Interest 1.06 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 58.21% vs -6.94% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 221.21% vs -45.90% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.33%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024